ARMISTICE CAPITAL, LLC - 31 Dec 2024 SCHEDULE 13G/A Report for Aligos Therapeutics, Inc. Common Stock, par value, $0.0001 per share (ALGS)

Filing Manager: ARMISTICE CAPITAL, LLC
Reporting Manager: Armistice Capital, LLC
Security: Aligos Therapeutics, Inc. Common Stock, par value, $0.0001 per share
Symbol: ALGS
Shares outstanding: 3,776,313 shares
Disclosed Ownership: 188,438 shares
Ownership: 5%
Form type: SCHEDULE 13G/A
Filing time: 14 Feb 2025, 16:56:39 UTC
Date of event: 31 Dec 2024
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Armistice Capital, LLC	5%	188,438	0	188,438	/s/ Steven Boyd	Steven Boyd - Managing Member
Steven Boyd	5%	188,438	0	188,438	/s/ Steven Boyd	Steven Boyd